Trial NCT02972450

View at ClinicalTrials.gov 
Org. Study IDs: EHVA T01/ANRS VRI05

Last trial update was posted on 2019-08-29

MeSH Interventions

Vaccines Vedolizumab

MeSH Conditions

Communicable Diseases Infections Persistent Infection

Other Conditions

HIV-1-infection

Stopping Reasons

Due to the bankruptcy of FITBiotech, the provider of the GTU DNA vaccine.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID